This paper is in the following e-collection/theme issue:

Consumer & Patient Education and Shared-Decision Making (771) Medicine 2.0: Social Media, Open, Participatory, Collaborative Medicine (1800) Pharmacovigilance (155) Adverse Drug Events Detection, Pharmacovigilance and Surveillance (188) Infodemiology and Infoveillance (1468) Prevention and Health Promotion (1147) Information Retrieval (325)

Published on in Vol 27 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/67361, first published .
Consumer Engagement With Risk Information on Prescription Drug Social Media Pages: Findings From In-Depth Interviews

Consumer Engagement With Risk Information on Prescription Drug Social Media Pages: Findings From In-Depth Interviews

Consumer Engagement With Risk Information on Prescription Drug Social Media Pages: Findings From In-Depth Interviews

Authors of this article:

Jacqueline B Amoozegar1 Author Orcid Image ;   Peyton Williams1 Author Orcid Image ;   Kristen C Giombi1 Author Orcid Image ;   Courtney Richardson1 Author Orcid Image ;   Ella Shenkar1 Author Orcid Image ;   Rebecca L Watkins1 Author Orcid Image ;   Amie C O'Donoghue2 Author Orcid Image ;   Helen W Sullivan2 Author Orcid Image
Article Authors Cited by Tweetations (1) Metrics

Jacqueline B Amoozegar   1 , MSPH ;   Peyton Williams   1 , MPH ;   Kristen C Giombi   1 , PhD ;   Courtney Richardson   1 , MPH ;   Ella Shenkar   1 , BA ;   Rebecca L Watkins   1 , BS ;   Amie C O'Donoghue   2 , PhD ;   Helen W Sullivan   2 , MPH, PhD

1 RTI International, Research Triangle Park, NC, United States

2 US Food and Drug Administration, Silver Spring, MD, United States

Corresponding Author:

  • Jacqueline B Amoozegar, MSPH
  • RTI International
  • 3040 East Cornwallis Road
  • Research Triangle Park, NC 27709-2194
  • United States
  • Phone: 1 919 541 6000
  • Email: jamoozegar@rti.org